Rein Therapeutics, Inc. ($RNTX)
Filing Information
| Accession Number | 0001193125-26-245832 |
|---|---|
| Form Type | 4 |
| Filing Date | May 29, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
47,060
Total Value
$49,560.64
P&L
+5.4% (+$2,675.96)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common stock , $0.001 par value | โ | May 21, 2026 | Purchase | 3,420 | $1.04 | $3,564.32 | 18,874 | Direct | โ | View Details | |
Director | Common stock , $0.001 par value | โ | May 22, 2026 | Purchase | 15,950 | $1.05 | $16,707.62 | 34,824 | Direct | โ | View Details | |
Director | Common stock , $0.001 par value | โ | May 26, 2026 | Purchase | 23,190 | $1.06 | $24,470.09 | 58,014 | Direct | โ | View Details | |
Director | Common stock , $0.001 par value | โ | May 27, 2026 | Purchase | 4,500 | $1.07 | $4,818.60 | 62,514 | Direct | โ | View Details |